EUVIMEDEUVIMED entdecken
Crossref

The changing virology and trends in resource utilization for bronchiolitis since COVID‐19

Allison Burks, William King, Mary Orr iD

Pediatric Pulmonology · 2023

DOI: 10.1002/ppul.26640 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Pulmonology, 2023. Verfasst von Allison Burks und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, COVID-19, Bronchiolitis, Respiratory Syncytial Virus, Human. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Bronchiolitis is a viral respiratory illness most commonly caused by respiratory syncytial virus (RSV). COVID‐19 disrupted typical patterns of viral transmission. Our study aimed to compare low value care for bronchiolitis in a tertiary emergency department (ED) in the United States from March 2017 to March 2022.

Methods

This was a descriptive cohort study through a retrospective chart review from 2017 to 2022 analyzing ED visits for bronchiolitis including disposition, disease severity, chest radiographs, albuterol, and high flow nasal cannula usage. A year was a 12‐month period from March to February.

Results

From 2017 to 2020, there were over 2000 ED visits for bronchiolitis per year (3.1% of all ED visits), which decreased to 450 visits for bronchiolitis (1%) in 2020–2021. Human rhino/enterovirus was the most common virus detected (92%) at that time, and admission rates, albuterol, high flow nasal cannula, and chest radiographs were all higher. The summer of 2021 had the highest visits across the 5‐study years with a return to previous rates of resource utilization.

Conclusions

Bronchiolitis ED visits due to RSV dramatically reduced during the first year of the COVID‐19 pandemic in 2020, with over 80% reduction in bronchiolitis visits from 2018 to 2019. While all ED visits fell in 2020, the proportion of visits due to bronchiolitis also decreased. There was an increase in lower value care during the rhinovirus dominant, low census period. As restrictions lifted in 2021, there was a large resurgence of RSV in the atypical summer months with a return of previous rates of resource utilization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Syncytial Virus InfectionsCOVID-19BronchiolitisRespiratory Syncytial Virus, HumanHumansUnited StatesInfantCohort StudiesRetrospective StudiesPandemicsAlbuterol

Stichwörter der Autor:innen

COVID-19RSVbronchiolitislow-value care

Substanzen

Albuterol

Autor:innen und Institutionen

  • Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA.

ORCID-Profile: Mary Orr

Zitieren

APA

Burks, A., King, W., & Orr, M. (2023). The changing virology and trends in resource utilization for bronchiolitis since COVID‐19. Pediatric Pulmonology. https://doi.org/10.1002/ppul.26640

Vancouver

Burks A, King W, Orr M. The changing virology and trends in resource utilization for bronchiolitis since COVID‐19. Pediatric Pulmonology. 2023. doi:10.1002/ppul.26640

BibTeX
@article{Burks2023,
  author = {Burks, Allison and King, William and Orr, Mary},
  title = {The changing virology and trends in resource utilization for bronchiolitis since COVID‐19},
  journal = {Pediatric Pulmonology},
  year = {2023},
  doi = {10.1002/ppul.26640}
}
Kostenlos starten →